Regeneron Pharmaceuticals (REGN) Other Working Capital Changes (2009 - 2026)

Regeneron Pharmaceuticals' Other Working Capital Changes history runs 18 years deep, the most recent figure standing at $198.6 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 1022.03% year-over-year to $198.6 million; the TTM figure through Mar 2026 stood at $556.2 million (up 231.86% YoY), while the FY2025 annual figure was $375.3 million, up 64.75% from the prior year.
• Other Working Capital Changes was $198.6 million for Q1 2026 at Regeneron Pharmaceuticals, down from $423.9 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $526.3 million in Q2 2024 to a low of -$252.0 million in Q3 2024.
• Historically, Other Working Capital Changes has averaged $58.1 million across 5 years, with a median of $17.7 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes plunged 1793.75% in 2022, then jumped 1074.78% in 2024.
• A 5-year view of Other Working Capital Changes shows it stood at -$18.7 million in 2022, then sank by 1218.18% to -$246.5 million in 2023, then soared by 49.53% to -$124.4 million in 2024, then soared by 440.76% to $423.9 million in 2025, then tumbled by 53.15% to $198.6 million in 2026.
• The last three Other Working Capital Changes figures came in at $198.6 million (Q1 2026), $423.9 million (Q4 2025), and $76.6 million (Q3 2025), per Business Quant data.